Sphera Funds Management Ltd. V Tv Therapeutics Inc. Transaction History

Sphera Funds Management Ltd.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2018 Aug 13, 2018	SELL	$0.71 - $4.04 $199,992 - $1.14 Million	-281,679 Closed	0 $0
Q4 2017 Feb 12, 2018	SELL	$3.9 - $7.77 $71,451 - $142,354	-18,321 Reduced 6.11%	281,679 $1.69 Million
Q3 2017 Nov 09, 2017	BUY	$3.83 - $6.07 $1.15 Million - $1.82 Million	300,000	300,000 $1.79 Million

243K

Ticker VTVT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 81,483,600
Market Cap $1.13B
Description
vTv Therapeutics Inc., a clinical-stage biopharmaceutical company, focuses on the development of orally administered treatments for diabetes. The company is developing TTP399, an orally administered, small molecule, and liver-selective glucokinase activator for the treatment of type 1 diabetes; and HPP737, an orally administered non-CNS penetran...

Get notified when there are updates to the investment portfolio of Sphera Funds Management Ltd., based on Form 13F filings with the SEC.

Stay updated on Sphera Funds Management Ltd. with notifications on news.